EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

CD25 expression marks an activated mast cell population in human nasal polyposis

Rizza U Santos, Jada Suber, Tahereh Derakhshan, Sri Vidya Niharika Gullapalli, Kenshiro Matsuda, Mabel C Zawacki, Juying Lai, Regan W Bergmark, Stella E Lee, Alice Z Maxfield, Rachel E Roditi, Carolyn H Baloh und 3 weitere

Journal of Allergy and Clinical Immunology · 2026-08 · 158 (2) · 443-452

DOI: 10.1016/j.jaci.2026.04.008 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Allergy and Clinical Immunology, 2026-08. Verfasst von Rizza U Santos und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Allergy and Clinical Immunology, Department of Medicine, Jeff and Penny Vinik Center for Allergic Disease Research, Mass General Brigham,…. Hauptthemen laut MEDLINE: Nasal Polyps, Mast Cells, Interleukin-2 Receptor alpha Subunit, Rhinosinusitis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, NHLBI NIH HHS, National Institutes of Health National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Chronic rhinosinusitis with nasal polyps (CRSwNP) is a TH2 disease characterized by heterogeneous mast cell hyperplasia. We previously used transcriptomics to identify discrete gene expression linked with intraepithelial mast cells expressing tryptase alone (MCTs), subepithelial mast cells coexpressing tryptase and chymase (MCTCs), and immature mast cells in CRSwNP. Although MCTCs were the only subset consistently observed in both CRSwNP and chronic rhinosinusitis without nasal polyps (CRSsNP), the degree to which they differ across disease states remains unexplored. OBJECTIVE: We sought to use transcriptomics and flow cytometry to compare MCTCs in CRSwNP with those in CRSsNP. METHODS: MCTCs were flow-sorted from CRSwNP and CRSsNP samples for RNA-sequencing analysis to identify differentially expressed genes and pathways across disease states. In silico observations were validated using flow cytometry on cryopreserved tissue samples from CRSwNP and CRSsNP and RNA sequencing of stimulated ex vivo-differentiated MCs. RESULTS: We found a significant increase in MCTC concentrations in CRSwNP donors, which were enriched for activation-associated pathways linked with differential expression of transcripts encoding proinflammatory mediators and cell receptors, including IL2RA. Validation studies highlighted significant cell surface expression of CD25 on MCTCs in CRSwNP. Ex vivo-stimulated primary MCs upregulated IL2RA in response to IL-33 stimulus. CONCLUSIONS: Our data show that MCTCs in CRSwNP exhibit an activated transcriptional phenotype with expression of transcripts encoding proinflammatory mediators and IL2RA. Moreover, the CD25 upregulation on MCTCs in CRSwNP suggests its potential to serve as an in vivo marker of activated MCTCs during allergic disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nasal PolypsMast CellsInterleukin-2 Receptor alpha SubunitRhinosinusitisHumansFemaleChronic DiseaseAdultMaleMiddle AgedTryptases

Stichwörter der Autor:innen

CD25CRSsNPCRSwNPChronic rhinosinusitisRNA-seqmast cells

Substanzen

Interleukin-2 Receptor alpha SubunitIL2RA protein, humanTryptases

Autor:innen und Institutionen

  • Division of Allergy and Clinical Immunology, Department of Medicine, Jeff and Penny Vinik Center for Allergic Disease Research, Mass General Brigham, Boston, Mass.
  • Division of Allergy and Clinical Immunology, Department of Medicine, Jeff and Penny Vinik Center for Allergic Disease Research, Mass General Brigham, Boston, Mass; Harvard Medical School, Boston, Mass.
  • Harvard Medical School, Boston, Mass; Department of Otolaryngology-Head and Neck Surgery, Mass General Brigham, Boston, Mass.
  • Division of Allergy and Clinical Immunology, Department of Medicine, Jeff and Penny Vinik Center for Allergic Disease Research, Mass General Brigham, Boston, Mass; Harvard Medical School, Boston, Mass; The Immune Tolera…
  • Division of Allergy and Clinical Immunology, Department of Medicine, Jeff and Penny Vinik Center for Allergic Disease Research, Mass General Brigham, Boston, Mass; Harvard Medical School, Boston, Mass. Electronic addres…

Förderung

  • NIAID NIH HHS
  • NHLBI NIH HHS
  • National Institutes of Health National Institute of Allergy and Infectious Diseases
  • National Heart Lung and Blood Institute

Zitieren

APA

Santos, R. U., Suber, J., Derakhshan, T., Gullapalli, S. V. N., Matsuda, K., Zawacki, M. C., Lai, J., Bergmark, R. W., Lee, S. E., Maxfield, A. Z., Roditi, R. E., Baloh, C. H., Laidlaw, T. M., Boyce, J. A., & Dwyer, D. F. (2026). CD25 expression marks an activated mast cell population in human nasal polyposis. Journal of Allergy and Clinical Immunology, 158(2), 443-452. https://doi.org/10.1016/j.jaci.2026.04.008

Vancouver

Santos RU, Suber J, Derakhshan T, Gullapalli SVN, Matsuda K, Zawacki MC, et al. CD25 expression marks an activated mast cell population in human nasal polyposis. Journal of Allergy and Clinical Immunology. 2026;158(2):443-452. doi:10.1016/j.jaci.2026.04.008

BibTeX
@article{Santos2026,
  author = {Santos, Rizza U and Suber, Jada and Derakhshan, Tahereh and Gullapalli, Sri Vidya Niharika and Matsuda, Kenshiro and Zawacki, Mabel C and Lai, Juying and Bergmark, Regan W and Lee, Stella E and Maxfield, Alice Z and Roditi, Rachel E and Baloh, Carolyn H and Laidlaw, Tanya M and Boyce, Joshua A and Dwyer, Daniel F},
  title = {CD25 expression marks an activated mast cell population in human nasal polyposis},
  journal = {Journal of Allergy and Clinical Immunology},
  year = {2026},
  volume = {158},
  number = {2},
  pages = {443--452},
  doi = {10.1016/j.jaci.2026.04.008}
}
Kostenlos starten →